incara pharma Pages on BioPortfolio:

BioPortfolio - Antioxidants
Incara Pharmaceuticals Corporation focuses on the protection and regeneration of tissue damaged by injury and disease. The company currently has programs in ...
http://www.bioportfolio.com/indepth/Antioxidants.html...

BioPortfolio - Incara Pharmaceuticals
BioPortfolio - incara pharma Email: info@incara.com. Incara Pharmaceuticals Corporation focuses on the protection and regeneration of tissue damaged by .
...
http://www.bioportfolio.com/search/Incara_Pharmaceuticals_.h...

BioPortfolio - Incara Pharmaceuticals
Incara Pharmaceuticals - BioPortfolio. ... BioPortfolio - incara pharma Email: info@incara.com. Incara Pharmaceuticals Corporation focuses on the protection
...
http://www.bioportfolio.com/search/Incara_Pharmaceuticals.ht...

BioPortfolio - Incara Pharmaceuticals Corp
Genzyme Biosurgery Geron Corporation Incara Pharmaceuticals-Vesta Therapeutics IsoTis Isto Technologies Kaleidos Pharma Kourion Therapeutics Miltenyi Biotec
...
http://www.bioportfolio.com/search/Incara_Pharmaceuticals_Co...

Results from other life science and pharmaceutical sites:

Aeolus Pharmaceuticals
Developing Novel Catalytic Anti-Oxident Therapeutics for Multiple Diseases and Disorders.
http://www.incara.com/...

BioSpace - Incara Pharmaceuticals Corporation News, Search Jobs ...
19 Oct 2005 ... Incara Pharmaceuticals Corporation 5251 DTC Parkway ... James D. Crapo, M.D. Named CEO Of Incara Pharmaceuticals Corp. ...
http://www.biospace.com/company_profile.aspx?CompanyId=76904...

Regenerative medicine Box 4
Bennett Love, vice president for corporate planning at Incara Pharmaceuticals ( Research Triangle Park, NC), which derives liver stem cells for ...
http://www.nature.com/materials/news/features/010301/nbt0301...

People - Nature Biotechnology
Incara Pharmaceuticals (Research Triangle Park, NC, USA) has announced James D. Crapo as the company's CEO. Since 1996, Dr. Crapo has been chairman of the ...
http://www.nature.com/nbt/journal/v22/n7/full/nbt0704-905.ht...

BioSpace offers Pharmaceutical, Biotechnology and Healthcare ...
Incara Pharmaceuticals Corp. (INCR) Announces Adjustment To Phase 1 Clinical Trial Of AEOL 10150 To Initiate Safety Studies Directly In Patients With ALS ...
http://www.biospace.com/news_by_disease_results.aspx?TheRxId...

Princeton - in the News - August 5 to 11, 1999
Incara Pharmaceuticals Corporation (Nasdaq: INCR) today announced the financial results for its third quarter of fiscal 1999, the three-month period ended ...
http://www.princeton.edu/pr/news/99/c/0811.htm...

Site-specific and temporally-regulated retinoblastoma protein ...
Correspondence to: J W Ludlow, Incara Pharmaceuticals, PO Box 14287, Research Triangle Park, North Carolina, NC 27709, USA; E-mail: JLudlow@incara.com ...
http://www.nature.com/onc/journal/v20/n29/abs/1204518a.html...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.